The trademark AMYRIAD THERAPEUTICS was filed by AmyriAD Therapeutics B.V., a corporation established under the laws of the Kingdom of the Netherlands (the "Applicant"). The application was published for oppositions on July 18, 2021, and received one opposition filed on September 22, 2021 by Amryt Pharmaceuticals DAC on Likelihood of confusion. the opponent was represented by Best Rechtsanwälte and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued September 22, 2021
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
Change of name and address of the trademark registration was recorded on July 4, 2021. Change of name and address of the trademark registration was recorded on July 14, 2021. Appointment and Replacement of representative of the trademark registration was recorded on December 20, 2021. Appointment and Replacement of representative of the trademark registration was recorded on October 19, 2022.